Back to All Events

World Medical Innovation Forum w/ JB Michel

JB Michel, Chief Architect BenevolentAI, will be presenting at the World Medical Forum as part of the Startup to Impact Session.

JB will do a short presentation of the company followed by a panel discussion alongside:

  • Art Papier, CEO of Visual Dx

  • Alex Zhavoronkov, CEO of Insilico

  • Charles Cadieu, CEO of Bay Labs

  • Sarah Beeby, SVP Life Sciences at Clinithink


JB's Biography

JB Michel BenevolentAI USA

PhD in Systems Biology (Harvard Medical School). Worked on antibiotic resistance, leading one of the first full-genome sequencing of a real world epidemic (B. dolosa in cystic fibrosis patients). At Palantir Technologies, led the integration of real world evidence, TCGA, and patient-level internal clinical trials at a major pharma for use in patient stratification. As Visiting Faculty at Google, worked on “research engines” to turn vast datasets (millions of books, planet-scale imagery) into scientific instruments for research (Google Books Ngram Viewer). Advisor to the Duchenne Regulatory Science Consortium, which centralizes patient-level clinical trials data to further research against DMD. Honorary PhD in Data Science (Claremont Graduate University), Forbes’ 30 under 30, TED Fellow.